Table 3.
Sequential changes after HFNC therapy. HFNC, high-flow nasal cannula.
| Total (n = 15) | HFNC success (n = 8) | HFNC failure (n = 7) |
||
|---|---|---|---|---|
| Intubation (n = 6) | Without intubation (n = 1) | |||
| HFNC duration (days), median (IQR) | 5 (2.5–6) | 5 (3.75–6.25) | 2.5 (2–4.5) | 7 |
| HFNC setting | ||||
| Maximum flow rates (L/min), median (IQR) | 50 (50–50) | 50 (50–50) | 50 (50–57.5) | 60 |
| Maximum FiO2 (%), median (IQR) | 80 (62.5–97.5) | 62.5 (60–68.75) | 95 (86.3–100) | 100 |
| Oxygen demand after HFNC (L/min), median (IQR) | N/A | 4 (4–4.25) | N/A | N/A |
| Death, n (%) | 3 (20%) | 0 | 2 (33.3%) | 1 (100%) |
HFNC, high-flow nasal cannula; IQR, interquartile range; FiO2, fraction of inspired oxygen, N/A, not available.